Bidding 20-24 Mar 2026, price band ₹117–124, lot 1000 shares.
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 1.87 | 53.5% |
| bHNI | 2.5 | 40.0% |
| sHNI | 0.62 | 100% |
| QIBs | 96.24🔥 | - |
| Retail | 0.83 | 100% |
| Total | 2.26 | - |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Speciality Medicines Limited sells medicines used to treat serious and long-term health conditions. These include diseases like cancer, immune-related disorders, neurological conditions, and rare illnesses. The company offers a wide range of medicines in different forms such as tablets, capsules, syrups, injections, and inhalers.It runs its business in two main ways. First, it gets medicines manufactured through third-party manufacturers and supplies them to customers, including in international markets. Second, it sources medicines from manufacturers and markets and distributes them to buyers. The company earns its revenue mainly by selling these pharmaceutical products. Overall, its focus is on providing specialised medicines that are used for complex treatments across different therapeutic areas.